1 May 2026 - The May 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few major new listings of note this month:

• Venetoclax (Venclexta) - new medicine
• Ibrutinib (Imbruvica) - new indication
• Letermovir (Prevymis) - new medicine
• Nivolumab (Opdivo) - new indication
• Ipilimumab (Yervoy) - new indication

Read New Zealand Pharmaceutical Schedule update